己二酸的清洁催化氧化合成研究进展

综述了近年来以环己烯、环己酮、环己醇或环己烷等作原料,以过氧化氢或氧气等为氧源,采用不同的催化体系清洁合成己二酸的新进展.指出:在这些方法中,改性的分子筛及负载型催化剂-双氧水体系将是今后己二酸清洁合成的重点研究方向.     

弱碱三元复合驱与强碱三元复合驱的对比

三元复合驱即将成为大庆油田的主导开发技术,为了推荐出合适的三元复合驱类型,对比研究了弱碱三元复合驱与强碱三元复合驱。研究表明,弱碱三元复合驱可以比水驱提高采收率20%以上,与强碱三元复合驱相当;弱碱三元复合驱与强碱三元复合驱乳化液粘度都超过100 mPa.s,两种类型三元复合乳化能力相差不多,甚至弱碱三元复合驱乳化能力还略强一些;在注采能力、采油速度方面,弱碱三元复合驱甚至高于强碱三元复合驱;特别是在结垢程度上,弱碱三元复合驱比强碱三元复合驱弱,对生产井的影响较小。因此,在三元复合驱推广应用时应当选用弱碱三元复合驱。     

Diffused Phase Transition Boosts Thermal Stability of High‐Performance Lead‐Free Piezoelectrics

High piezoelectricity of (K,Na)NbO₃ (KNN) lead‐free materials benefits from a polymorphic phase transition (PPT) around room temperature, but its temperature sensitivity has been a bottleneck impeding their applications. It is found that good thermal stability can be achieved in CaZrO₃‐modified KNN lead‐free piezoceramics, in which the normalized strain d ₃₃* almost keeps constant from room temperature up to 140 °C. In situ synchrotron X‐ray diffraction experiments combined with permitivity measurements disclose the occurrence of a new phase transformation under an electrical field, which extends the transition range between tetragonal and orthorhombic phases. It is revealed that such an electrically enhanced diffused PPT contributed to the boosted thermal stability of KNN‐based lead‐free piezoceramics with high piezoelectricity. The present approach based on phase engineering should also be effective in endowing other lead‐free piezoelectrics with high piezoelectricity and good temperature stability.     

EPR studies of (Bi, Pb)-2223 phase substituted by Ruthenium ions

This work studied X-ray powder diffraction (XRD), electrical resistivity and electron paramagnetic resonance (EPR) measurements for Bi_1.8Pb_0.4Sr₂Ca_2.1Cu_3−xRu_xO_10+δ (0.0 ≤ x ≤ 0.4) superconducting samples. XRD analysis and electrical resistivity data showed that the low-content of Ru, x ≤ 0.05, enhanced both the phase formation and the superconducting transition temperature of (Bi, Pb)-2223 phase. A phase change from (Bi, Pb)-2223 phase to (Bi, Pb)-2212 phase was reported for x ≥ 0.15. Two EPR lines were observed for 0.0 ≤ x ≤ 0.075, indicating the presence of both (Bi, Pb)-2223 and (Bi, Pb)-2212 phases. While, one EPR line was observed for x ≥ 0.15, corresponding to the (Bi, Pb)-2212 phase formation. The number of spins (N) participating in the resonance and its spin paramagnetic susceptibility (χ), for the two phases, were calculated as a function of both Ru-content and temperature. In addition, we reported the variation of activation energy (E_a), Curie constant (C), Curie temperature (θ) and effective magnetic moment (μ) with Ru-content.     

High avidity CTLs for two self-antigens demonstrate superior in vitro and in vivo antitumor efficacy

A majority of the human tumor-associated Ags characterized to date are derived from nonmutated "self"-proteins. Little is currently understood about the nature of the self-reactive lymphocytes that recognize these Ags. We recently characterized two nonmutated tumor-associated Ags for the B16 murine melanoma: tyrosinase-related protein-2 (TRP-2) and the endogenous retroviral envelope protein, p15E. We previously reported that both TRP-2 and p15E reactive CTL could be detected in the spleens of naive animals after a single in vitro stimulation using 10(-5)-10(-6) M of the appropriate Kb-binding 9-amino acid epitope. In this report we show that the CTL found in naive animals are low avidity lymphocytes, that respond only to high concentrations of peptide in vitro. We demonstrate that titration of in vitro-stimulating peptide to limiting concentrations distinguishes qualitative differences in the lymphocyte reactivity to these two Ags between vaccinated and unvaccinated animals. We further demonstrate that in vitro expansion of CTL in either high or low concentrations of stimulating peptide generated CTL cultures with different avidities for the relevant epitopes. CTL expanded in low concentrations demonstrated higher avidity for peptide-pulsed targets and better tumor recognition, when compared to CTL generated in the presence of high concentrations of Ag. More importantly, high avidity CTL demonstrated superior in vivo antitumor activity. These results demonstrate that qualitative differences in the CTL that recognize these two self-Ags are critically important to their in vitro and in vivo anti-tumor efficacy.     

Prediction of anticoagulation during hemodialysis by population kinetics and an artificial neural network

All systems currently used for routine hemodialysis require heparin administration to prevent blood clotting in the extracorporeal circuit. We tested the hypothesis that population-based statistical techniques can be used to predict heparin concentrations during routine hemodialysis. Two predictive models were developed, one based on nonlinear mixed effects modeling (NONMEM) and the other on a multilayer perceptron neural network. Serial clotting time data were obtained from forty-nine patients and used to develop the models. The models were used to predict the clotting times of 70 patients in a prospective test. We determined that the neural network provided greater precision, had fewer outliers in its predictions, and did not have the model misspecification in bolus administration that the NONMEM predictions demonstrated. A final NONMEM model was developed using all data from 119 patients to identify important covariates for predicting the heparin pharmacodynamic parameters, volume of distribution, and clearance. Both the volume of distribution and clearance increased following the initiation of dialysis and as the patient's baseline clotting time increased. The volume of distribution also increased as the patient's weight increased but was decreased by smoking and diabetes. Population-based statistical techniques may provide a useful alternative to existing methods for prescribing heparin.     

Osteopenia in children surviving brain tumours

Mature and post-translational precursor gastrin forms are growth factors for colorectal tumours. The immunogen Gastrimmune is composed of the amino terminus of gastrin-17 linked to diphtheria toxoid and raises antibodies in situ which neutralise amidated and glycine-extended gastrin-17. The aim of the study was to determine the effect of treatment with 5-fluorouracil(5-FU)/leucovorin on the antibody titres induced by Gastrimmune and the effect of combination therapy on the growth of the rat colon tumour DHDK12. Gastrimmune was administered to rats s.c. at 3 weekly intervals. The rat colon tumour line DHDK12 was injected into the abdominal wall of BDIX rats. Combinations of 5-FU/leucovorin were injected i.v. on days 1, 3 and 5, with the cycle repeated every 4 weeks. Antibody titres were measured by an ELISA technique. Antibody titres were followed for 40 weeks after Gastrimmune (500 microg.ml(-1)) immunization, with titres peaking between 10 and 20 weeks after a single immunisation and falling by week 30. At termination, no effect was observed on either the histological appearance of the gastro-intestinal tract or the proliferation of the colonic mucosa. Pre- and post-treatment with 5-FU/leucovorin (30 mg.kg(-1)) had no effect on the kinetics and level of antibody response to Gastrimmune. Gastrimmune (200 microg.ml(-1)) and 5-FU/leucovorin combinations (12.5 and 20 mg.kg(-1)) increased the therapeutic effects on the in vivo growth of DHDK12 tumors when compared to the agents given singly. Gastrimmune immunisation may be a therapeutic option for the treatment of colorectal cancer in combination with 5-FU/leucovorin.